A wound dressing with built-in pain medication has been developed by a Danish company and will become available in the UK in July. The dressing - called Biatain-Ibu - is able to reduce ongoing pain for people with chronic wounds by delivering pain medication directly into the wound. People with diabetes can experience nerve damage or circulation problems which can lead to foot and leg ulcers and other chronic wounds. Around 90,000 people with diabetes will develop foot ulcers in one year. The dressing works by evaporating the wound fluid and constantly delivering low-dosage pain relief. Clinical studies show a significant reduction of pain within a few hours of the dressing being applied. The sustained pain reducing effect of the dressing will last for up to seven days. Amanda Eden, Care Adviser at Diabetes UK, said: “Diabetes damages nerves and can affect circulation which can cause long lasting ulcers or wounds. Although this treatment will not be suitable for everyone anything that could increase the choice of treatment for pain relief is a welcome development.” Good diabetes control reduces the chances of developing complications like nerve damage or circulation problems. For more information on the product when it becomes available in the UK, discuss with your healthcare team.